The alpha-
adrenoceptor blocking properties of the two enantiomers of
idazoxan have been investigated in rats, dogs and chicks, as well as their agonistic effects in pithed rats. At peripheral sites, (+)
idazoxan was equipotent for blocking both postsynaptic alpha-1 and alpha-2
adrenoceptors of the rat and revealed to be a potent antagonist at presynaptic sites of rats and dogs. (-)
Idazoxan revealed to be selective for postsynaptic alpha-2
adrenoceptors with an apparent selectivity ratio of about 10. This selectivity of (-)
idazoxan was greater in vitro. (-)
Idazoxan also antagonized presynaptic alpha-2
adrenoceptors of rats and dogs. At central sites, (+) and (-)
idazoxan antagonized the
hypotension,
bradycardia, inhibition of sympathetic nerve activity induced by
clonidine in rats and dogs and sedation induced by
clonidine and
azepexole in chicks. Although (+)
idazoxan was more potent than (-)
idazoxan, binding studies revealed (-)
idazoxan to be more selective than (+)
idazoxan at central sites. It is concluded that (+)
idazoxan antagonizes both alpha-1 and alpha-2
adrenoceptors and (-)
idazoxan is selective for alpha-2
adrenoceptors. In the pithed rat, only (-)
idazoxan possesses both alpha-1 and alpha-2 agonistic effects. These results show little differences between the two enantiomers of
idazoxan as for those of
imidazoline derivatives.